The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic.

Medicare seeks public comments as the agency plans to list up to 15 additional drugs selected for the third round of pricing ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...

President Trump’s executive order to lower drug prices through cross-agency action left pharma leaders scrambling to make ...

An executive order from President Trump aims to make deep cuts to prescription drug costs, putting GOP lawmakers who have ...

CMS said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next year. For the first time, the list would include drugs ...